SLC12A5 and pancreatic adenocarcinoma: To investigate the association between bM2-like TAMs and PAAD stage, we divided PAAD patients into three groups based on the expression of SLC12A5 and ENPP2 (n (bTAMs_high) = 60, n (bTAMs_medium) = 58, n (bTAMs_low) = 60).